切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库（CSCD）来源期刊

高级检索
中华重症医学电子杂志

中华重症医学电子杂志 ›› 2024, Vol. 10 ›› Issue (02) : 189 -195. doi: 10.3877/cma.j.issn.2096-1537.2024.02.014

综述

脓毒症液体复苏治疗策略的研究进展
庞明敏1, 闫美辰1, 刘光凤1, 宫继斌1, 许娜娜2, 郑玥3, 范少华4, 王昊1,†()   
  1. 1. 250000　济南，山东大学齐鲁医院重症医学科
    2. 250000　济南，山东大学齐鲁医院心外监护室
    3. 250000　济南，山东大学齐鲁医院急诊科
    4. 250000　济南，济南市中心医院重症医学科
  • 收稿日期:2023-04-18 出版日期:2024-05-28
  • 通信作者: 王昊
  • 基金资助:
    国家自然科学基金资助项目(82072231); 山东省泰山学者计划项目(tsqn202103165); 山东大学临床研究中心项目(2020SDUCRCC013)

Progress in fluid resuscitation strategy in septic patients

Mingmin Pang1, Meichen Yan1, Guangfeng Liu1, Jibin Gong1, Nana Xu2, Yue Zheng3, Shaohua Fan4, Hao Wang1,†()   

  1. 1. Department of Critical Care Medicine, Qilu Hospital of Shandong University, Jinan 250000, China
    2. Department of Extracardiac Care Unit, Qilu Hospital of Shandong University, Jinan 250000, China
    3. Department of Emergency, Qilu Hospital of Shandong University, Jinan 250000, China
    4. Department of Critical Care Medicine, Jinan Central Hospital, Jinan 250000, China
  • Received:2023-04-18 Published:2024-05-28
  • Corresponding author: Hao Wang
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

庞明敏, 闫美辰, 刘光凤, 宫继斌, 许娜娜, 郑玥, 范少华, 王昊. 脓毒症液体复苏治疗策略的研究进展[J]. 中华重症医学电子杂志, 2024, 10(02): 189-195.

Mingmin Pang, Meichen Yan, Guangfeng Liu, Jibin Gong, Nana Xu, Yue Zheng, Shaohua Fan, Hao Wang. Progress in fluid resuscitation strategy in septic patients[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2024, 10(02): 189-195.

脓毒症是一个重大的全球健康问题，病死率高。液体复苏治疗是脓毒症早期紧急治疗中的重要一环，及时有效的液体复苏可显著降低患者的病死率。近年来，随着对脓毒症发生机制认知的进一步深化和循证医学证据的不断增加，脓毒症液体复苏治疗的方法和策略也随之更新。本文对脓毒症液体复苏治疗策略的进展进行综述，以期更新对脓毒症液体复苏的认识。

关键词: 脓毒症, 脓毒症休克, 液体复苏

Sepsis is a major global health problem with a high mortality. Fluid resuscitation is an important part of early emergency treatment of sepsis, and timely and effective fluid resuscitation can significantly reduce mortality. In recent years, with further understanding sepsis and continuous increase of evidence-based evidence, fluid resuscitation treatment have also been updated. This article reviews advances in fluid resuscitation strategies for sepsis with a view to update understanding of fluid resuscitation in sepsis.

Key words: Sepsis, Septic shock, Fluid resuscitation
14
ARISE Investigators, ANZICS Clinical Trials Group, Peake SL, et al. Goal-directed resuscitation for patients with early septic shock [J]. N Engl J Med, 2014, 371(16): 1496-1506.
15
Mouncey PR, Osborn TM, Power GS, et al. Protocolised Management In Sepsis (ProMISe): a multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shock [J]. Health Technol Assess Winch Engl, 2015, 19(97): i-xxv, 1-150.
16
Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 [J]. Intensive Care Med, 2017, 43(3): 304-377.
17
Koh IHJ, Menchaca-Diaz JL, Koh TH, et al. Microcirculatory evaluation in sepsis: a difficult task [J]. Shock Augusta Ga, 2010, 34 Suppl 1: 27-33.
18
Kraut JA, Madias NE. Lactic acidosis [J]. N Engl J Med, 2014, 371(24): 2309-2319.
19
MacLean LD, Mulligan WG, McLean AP, et al. Patterns of septic shock in man--a detailed study of 56 patients [J]. Ann Surg. 1967, 166(4): 543-562.
20
Vincent JL, Mongkolpun W. Current management of Gram-negative septic shock [J]. Curr Opin Infect Dis, 2018, 31(6): 600-605.
21
Acheampong A, Vincent JL. A positive fluid balance is an independent prognostic factor in patients with sepsis [J]. Crit Care Lond Engl, 2015, 19(1): 251.
22
Marik PE, Linde-Zwirble WT, Bittner EA, et al. Fluid administration in severe sepsis and septic shock, patterns and outcomes: an analysis of a large national database [J]. Intensive Care Med, 2017, 43(5): 625-632.
23
Hjortrup PB, Haase N, Bundgaard H, et al. Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial [J]. Intensive Care Med, 2016, 42(11): 1695-1705.
24
Cordemans C, De Laet I, Van Regenmortel N, et al. Aiming for a negative fluid balance in patients with acute lung injury and increased intra-abdominal pressure: a pilot study looking at the effects of PAL-treatment [J]. Ann Intensive Care, 2012, 2 Suppl 1: S15.
25
Vincent JL, De Backer D. Circulatory shock [J]. N Engl J Med, 2013, 369(18): 1726-1734.
26
Casey JD, Brown RM, Semler MW. Resuscitation fluids [J]. Curr Opin Crit Care, 2018, 24(6): 512-518.
27
任建安. 外科感染性疾病的血液滤过治疗 [J]. 中国实用外科杂志, 2008, 28(6): 429-430.
28
Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 [J]. Intensive Care Med, 2021, 47(11): 1181-1247.
29
Bentzer P, Griesdale DE, Boyd J, et al. Will this hemodynamically unstable patient respond to a bolus of intravenous fluids? [J]. JAMA, 2016, 316(12): 1298-1309.
30
Cherpanath TGV, Geerts BF, Lagrand WK, et al. Basic concepts of fluid responsiveness [J]. Neth Heart J Mon J Neth Soc Cardiol Neth Heart Found, 2013, 21(12): 530-536.
31
Marik PE, Cavallazzi R. Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense [J]. Crit Care Med, 2013, 41(7): 1774-1781.
32
Shah MR, Hasselblad V, Stevenson LW, et al. Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials [J]. JAMA, 2005, 294(13): 1664-1670.
33
Hanson J, Lam SWK, Alam S, et al. The reliability of the physical examination to guide fluid therapy in adults with severe falciparum malaria: an observational study [J]. Malar J, 2013, 12: 348.
34
Saugel B, Kirsche SV, Hapfelmeier A, et al. Prediction of fluid responsiveness in patients admitted to the medical intensive care unit [J]. J Crit Care, 2013, 28(4): 537.e1-9.
35
Fessler HE, Brower RG, Wise RA, et al. Mechanism of reduced LV afterload by systolic and diastolic positive pleural pressure [J]. J Appl Physiol (1985), 1988, 65(3): 1244-1250.
36
Monnet X, Marik PE, Teboul JL. Prediction of fluid responsiveness: an update [J]. Ann Intensive Care, 2016, 6(1): 111.
37
Monnet X, Teboul JL. Passive leg raising [J]. Intensive Care Med, 2008, 34(4): 659-663.
38
Borthwick HA, Brunt LK, Mitchem KL, et al. Does lactate measurement performed on admission predict clinical outcome on the intensive care unit? A concise systematic review [J]. Ann Clin Biochem, 2012, 49(Pt 4): 391-394.
39
Karon BS, Tolan NV, Wockenfus AM, et al. Evaluation of lactate, white blood cell count, neutrophil count, procalcitonin and immature granulocyte count as biomarkers for sepsis in emergency department patients [J]. Clin Biochem, 2017, 50(16-17): 956-958.
40
张井晓, 尹梅, 陈晓梅, 等. 早期乳酸面积对老年脓毒性休克患者预后评估的价值[J]. 中华医学杂志, 2016, 96(33): 2640-2643.
41
Wang H, Li Z, Yin M, et al. Combination of acute physiology and chronic health evaluation Ⅱ score, early lactate area, and N-terminal prohormone of brain natriuretic peptide levels as a predictor of mortality in geriatric patients with septic shock [J]. J Crit Care, 2015, 30(2): 304-309.
42
Ait-Oufella H, Bige N, Boelle PY, et al. Capillary refill time exploration during septic shock [J]. Intensive Care Med, 2014, 40(7): 958-964.
43
Vignon P, Repessé X, Bégot E, et al. Comparison of echocardiographic indices used to predict fluid responsiveness in ventilated patients [J]. Am J Respir Crit Care Med, 2017, 195(8): 1022-1032.
44
Corl KA, Azab N, Nayeemuddin M, et al. Performance of a 25% inferior vena cava collapsibility in detecting fluid responsiveness when assessed by novice versus expert physician sonologists [J]. J Intensive Care Med, 2020, 35(12): 1520-1528.
45
Orso D, Paoli I, Piani T, et al. Accuracy of ultrasonographic measurements of inferior vena cava to determine fluid responsiveness: a systematic review and meta-analysis [J]. J Intensive Care Med, 2020, 35(4): 354-363.
46
王小亭, 刘大为, 于凯江, 等. 中国重症超声专家共识 [J]. 中华内科杂志, 2016, 55(11): 900-912.
47
张磊云, 李少洪, 姚一鸣, 等. 床旁超声指导下早期液体复苏治疗重症脓毒症的临床效果 [J]. 智慧健康, 2022, 8(31): 25-28, 32.
48
张功伟, 王伟, 张诗渊, 等. 床旁超声与脉搏指示连续心排血量监测在脓毒症休克患者早期液体复苏治疗中的疗效比较 [J]. 中国现代医学杂志, 2022, 32(20): 8-13.
49
Awad S, Allison SP, Lobo DN. The history of 0.9% saline [J]. Clin Nutr Edinb Scotl, 2008, 27(2): 179-188.
50
Yunos NM, Bellomo R, Glassford N, et al. Chloride-liberal vs. chloride-restrictive intravenous fluid administration and acute kidney injury: an extended analysis [J]. Intensive Care Med, 2015, 41(2): 257-264.
51
Krajewski ML, Raghunathan K, Paluszkiewicz SM, et al. Meta-analysis of high- versus low-chloride content in perioperative and critical care fluid resuscitation [J]. Br J Surg, 2015, 102(1): 24-36.
1
Ladzinski AT, Thind GS, Siuba MT. Rational fluid resuscitation in sepsis for the hospitalist: a narrative review [J]. Mayo Clin Proc, 2021, 96(9): 2464-2473.
2
Foëx BA. How the cholera epidemic of 1831 resulted in a new technique for fluid resuscitation [J]. Emerg Med J EMJ, 2003, 20(4): 316-318.
3
Hammond DA, Lam SW, Rech MA, et al. Balanced crystalloids versus saline in critically ill adults: a systematic review and meta-analysis [J]. Ann Pharmacother, 2020, 54(1): 5-13.
4
Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock [J]. N Engl J Med, 2001, 345(19): 1368-1377.
5
Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis [J]. Intensive Care Med, 2010, 36(2): 222-231.
6
Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 [J]. Intensive Care Med, 2021, 47(11): 1181-1247.
7
Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 [J]. Intensive Care Med, 2013, 39(2): 165-228.
8
Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign Bundle: 2018 update [J]. Intensive Care Med, 2018, 44(6): 925-928.
9
吴飞, 陈含冰, 陈齐红, 等. 初始30 mL/kg液体复苏完成时间对脓毒性休克患者预后的影响 [J]. 中华危重病急救医学, 2021, 33(7): 803-808.
10
Owens TM, Watson WC, Prough DS, et al. Limiting initial resuscitation of uncontrolled hemorrhage reduces internal bleeding and subsequent volume requirements [J]. J Trauma, 1995, 39(2): 200-207, discussion 208-209.
11
Kelm DJ, Perrin JT, Cartin-Ceba R, et al. Fluid overload in patients with severe sepsis and septic shock treated with early goal-directed therapy is associated with increased acute need for fluid-related medical interventions and hospital death [J]. Shock Augusta Ga, 2015, 43(1): 68-73.
12
Jozwiak M, Hamzaoui O, Monnet X, et al. Fluid resuscitation during early sepsis: a need for individualization [J]. Minerva Anestesiol, 2018, 84(8): 987-992.
13
Lilly CM. Protocol-based care for early septic shock [J]. N Engl J Med, 2014, 371(4): 386-387.
52
Yunos NM, Bellomo R, Hegarty C, et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults [J]. JAMA, 2012, 308(15): 1566-1572.
53
Zampieri FG, Machado FR, Biondi RS, et al. Effect of intravenous fluid treatment with a balanced solution vs 0.9% saline solution on mortality in critically ill patients: the BaSICS randomized clinical trial [J]. JAMA, 2021, 326(9): 1-12.
54
孙习鹏, 陆瑶华, 李星霞, 等. 人血白蛋白与晶体液对成人脓毒症及脓毒症休克患者液体复苏作用Meta分析 [J]. 医药导报, 2017, 36(7): 804-808.
55
He H, Liu D, Ince C. Colloids and the Microcirculation [J]. Anesth Analg, 2018, 126(5): 1747-1754.
56
Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit [J]. N Engl J Med, 2004, 350(22): 2247-2256.
57
Caironi P, Tognoni G, Masson S, et al. Albumin replacement in patients with severe sepsis or septic shock [J]. N Engl J Med, 2014, 370(15): 1412-1421.
58
Park CHL, de Almeida JP, de Oliveira GQ, et al. Lactated ringer's versus 4% albumin on lactated Ringer's in early sepsis therapy in cancer patients: a pilot single-center randomized trial [J]. Crit Care Med, 2019, 47(10): e798-e805.
59
Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care [J]. N Engl J Med, 2012, 367(20): 1901-1911.
60
Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis [J]. N Engl J Med, 2012, 367(2): 124-134.
61
Haase N, Perner A, Hennings LI, et al. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis [J]. BMJ, 2013, 346: f839.
62
Rochwerg B, Alhazzani W, Sindi A, et al. Fluid resuscitation in sepsis: a systematic review and network meta-analysis [J]. Ann Intern Med, 2014, 161(5): 347-355.
63
Annane D, Siami S, Jaber S, et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial [J]. JAMA, 2013, 310(17): 1809-1817.
64
殷晓春, 王荣民, 何玉凤, 等. 人工氧载体研究进展 [J]. 化学进展, 2011, 23(5): 963-973.
65
孙绪德, 柴伟, 高昌俊, 等. 高氧液对家兔心肌缺血/再灌注细胞凋亡的影响 [J]. 中国临床康复, 2003, 7(17): 2434-2435.
66
孙绪德, 柴伟, 马加海, 等. 高氧液对家兔心肌缺血再灌注损伤生化指标和超微结构的影响 [J]. 第四军医大学学报, 2001, 22(13): 1176-1178.
67
孙绪德, 柴伟, 张贵和, 等. 高氧液在抢救重度失血性休克中的临床应用 [J]. 临床麻醉学杂志, 2003, 19(6): 346-347.
[1] 贾亚娟, 蒙钰铭, 高志伟, 高素敏, 张劲松, 孙虹. 血小板与淋巴细胞比值、降钙素原和白细胞介素6联合检测对脓毒症患者预后价值的研究[J]. 中华危重症医学杂志(电子版), 2024, 17(02): 118-123.
[2] 冯芳, 陈宇, 杨静, 满珂, 蔡红燕, 李群. ω-3鱼油脂肪乳注射液在脓毒症患者中的应用：前瞻性、随机对照、先导试验[J]. 中华危重症医学杂志(电子版), 2024, 17(02): 136-139.
[3] 柯晴潆, 沈延飞, 许强宏, 蔡国龙. 预测脓毒性心肌病患者院内死亡风险列线图模型的构建及验证[J]. 中华危重症医学杂志(电子版), 2024, 17(01): 10-18.
[4] 姚咏明. 如何精准评估烧伤脓毒症患者免疫状态[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 552-552.
[5] 中华医学会烧伤外科学分会小儿烧伤学组. 儿童烧伤早期休克液体复苏专家共识(2023版)[J]. 中华损伤与修复杂志(电子版), 2023, 18(05): 371-376.
[6] 顾晓凌, 吴冠楠, 宋勇. 核因子E2相关因子2(Nrf2)与铁死亡在脓毒症相关急性肺损伤中的研究进展[J]. 中华肺部疾病杂志(电子版), 2024, 17(02): 324-328.
[7] 张宪超, 张实. 基于转录组数据分析识别脓毒症肺炎免疫表型[J]. 中华肺部疾病杂志(电子版), 2023, 16(06): 761-765.
[8] 尚明煦, 魏丽娟, 是若春. 血清CRP、BNP、PCT与脓毒症并发ALI程度的相关性[J]. 中华肺部疾病杂志(电子版), 2023, 16(06): 766-769.
[9] 姜东, 冉龙艳, 雷传江, 徐静. 脓毒症的前世今生及序贯器官衰竭认知及理念[J]. 中华肺部疾病杂志(电子版), 2023, 16(05): 605-610.
[10] 李莉, 张丽娜, 钱招昕. 亚甲蓝——脓毒症休克的“魔法锦囊”？[J]. 中华重症医学电子杂志, 2024, 10(02): 136-142.
[11] 张引, 李国强. 亚甲蓝治疗脓毒症休克的研究进展[J]. 中华重症医学电子杂志, 2024, 10(02): 143-147.
[12] 刘霞, 赵双平. TDM指导特重度烧伤脓毒症患者多黏菌素B的个体化治疗一例[J]. 中华重症医学电子杂志, 2024, 10(01): 85-89.
[13] 胡杰, 蔡国龙. 脓毒症合并低心功能指数患者PiCCO参数的聚类分析[J]. 中华重症医学电子杂志, 2024, 10(01): 25-30.
[14] 弥亮钰, 隆云. 心脏效率在血流动力学治疗中的研究进展[J]. 中华重症医学电子杂志, 2024, 10(01): 72-78.
[15] 谭睿, 王晶, 於江泉, 郑瑞强. 脓毒症中高密度脂蛋白、载脂蛋白A-I和血清淀粉样蛋白A的作用研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(06): 749-753.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号